Prognostic value of early in-hospital glycemic excursion in elderly patients with acute myocardial infarction

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Su, Gong ^a   Mi, Shu hua ^a   Li, Zhao ^b   Tao, Hong ^a   Yang, Hong xia ^a   Zheng, Hong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Beijing Emergence Medical Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

ACUTE HEART FAILURE; ACUTE HEART INFARCTION; AGED; ANTIDIABETIC ACTIVITY; ARTICLE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART DEATH; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; RISK; SCORING SYSTEM;

AGED; BLOOD GLUCOSE; DISEASE-FREE SURVIVAL; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; GLYCEMIC INDEX; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS;

EID: 84873520077     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-33     Document Type: Article

References (28)

1. White HD, Aylward PE, Huang Z, Dalby AJ, Weaver WD, Barvik S, Marin-Neto JA, Murin J, Nordlander RO, van Gilst WH, Zannad F, McMurray JJ, Califf RM, Pfeffer MA, . VALIANT Investigators Mortality and morbidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the valsartan in acute myocardial infarction trial (VALIANT). Circulation 2005, 112:3391-3399. 10.1161/CIRCULATIONAHA.105.551143, 16301343, VALIANT Investigators.
2. Martins RA, Jones JG, Cumming SP, Coelho e Silva MJ, Teixeira AM, Veríssimo MT. Glycated hemoglobin and associated risk factors in older adults. Cardiovasc Diabetol 2012, 11:13. 10.1186/1475-2840-11-13, 3395860, 22309488.
3. Cakmak M, Cakmak N, Cetemen S, Tanriverdi H, Enc Y, Teskin O, Kilic ID. The value of admission glycosylated hemoglobin level in patients with acute myocardial infarction. Can J Cardiol 2008, 24:375-378. 10.1016/S0828-282X(08)70600-7, 2643139, 18464942.
4. Wahsb NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL, . ICONS Investigators Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?. J Am Coll Cardiol 2002, 40:1748-1754. 10.1016/S0735-1097(02)02483-X, 12446057, ICONS Investigators.
5. Stranders I, Diamant M, van Gelder RE, Spruijt HJ, Twisk JW, Heine RJ, Visser FC. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 2004, 164:982-988. 10.1001/archinte.164.9.982, 15136307.
6. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, Krumholz HM. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 2005, 111:3078-3086. 10.1161/CIRCULATIONAHA.104.517839, 15939812.
7. Hu Y, Liu W, Huang R, Zhang X. Postchallenge plasma glucose excursions, carotid intima-media thickness, and risk factors for atherosclerosis in Chinese population with type 2 diabetes. Atherosclerosis 2010, 210:302-306. 10.1016/j.atherosclerosis.2009.11.015, 20005514.
8. Su G, Mi S, Tao H, Li Z, Yang H, Zheng H, Zhou Y, Ma C. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol 2011, 10:19. 10.1186/1475-2840-10-19, 3056765, 21349201.
9. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999, 130:461-470.
10. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van De Werf F, Avezum A, Goodman SG, Flather MD, Fox KA, . Global Registry of Acute Coronary Events Investigators Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003, 163:2345-2353. 10.1001/archinte.163.19.2345, 14581255, Global Registry of Acute Coronary Events Investigators.
11. American Diabetes Association Standards of medical care in diabetes-2010. Diabetes Care 2010, 33(Suppl 1):S11-S61. 2797382, 20042772, American Diabetes Association.
12. Monnier L, Colette C, Owens DR. Glycemic variability: The third component of the dysglycemia in diabetes. Is it important? How to measure it?. J Diabetes Sci Technol 2008, 2:1094-1100. 2769808, 19885298.
13. Monnier L, Colette C. Glycemic variability: should we and can we prevent it?. Diabetes Care 2008, 31(Suppl 2):S150-S154.
14. Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, Boemi M, Giugliano D. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008, 57:1349-1354. 10.2337/db08-0063, 18299315.
15. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fuctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006, 295:1681-1687. 10.1001/jama.295.14.1681, 16609090.
16. Temelkova-Kurktschiev TS, Koehler C, Henkel E, Leonhardt W, Fuecker K, Hanefeld M. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 2000, 23:1830-1834. 10.2337/diacare.23.12.1830, 11128361.
17. Muggeo M, Zoppini G, Bonora E, Brun E, Bonadonna RC, Moghetti P, Verlato G. Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona diabetes study. Diabetes Care 2000, 23:45-50. 10.2337/diacare.23.1.45, 10857967.
18. Dossett LA, Cao H, Mowery NT, Dortch MJ, Morris JM, May AK. Blood glucose variability is associated with mortality in the surgical intensive care unit. Am Surg 2008, 74:679-685.
19. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 2008, 36:3008-3013. 10.1097/CCM.0b013e31818b38d2, 18824908.
20. Takada JY, Ramos RB, Roza LC, Avakian SD, Ramires JA, Mansur Ade P. In-hospital death in acute coronary syndrome was related to admission glucose in men but not in women. Cardiovasc Diabetol 2012, 11:47. 10.1186/1475-2840-11-47, 3355051, 22553938.
21. Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 2003, 52:2795-2804. 10.2337/diabetes.52.11.2795, 14578299.
22. Azuma K, Kawamori R, Toyofuku Y, Kitahara Y, Sato F, Shimizu T, Miura K, Mine T, Tanaka Y, Mitsumata M, Watada H. Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta. Arterioscler Thromb Vasc Biol 2006, 26:2275-2280. 10.1161/01.ATV.0000239488.05069.03, 16888238.
23. Takei Y, Tomiyama H, Tanaka N, Yamashina A. Close relationship between sympathetic activation and coronary microvascular dysfunction during acute hyperglycemia in subjects with atherosclerotic risk factors. Circ J 2007, 71:202-206. 10.1253/circj.71.202, 17251667.
24. Carmen Wong KY, Wong V, Ho JT, Torpy DJ, McLean M, Cheung NW. High cortisol levels in hyperglycaemic myocardial infarct patients signify stress hyperglycaemia and predict subsequent normalization of glucose tolerance. Clin Endocrinol (Oxf) 2010, 72:189-195.
25. Timmer JR, Hoekstra M, Nijsten MW, van der Horst IC, Ottervanger JP, Slingerland RJ, Dambrink JH, Bilo HJ, Zijlstra F, van't Hof AW. Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention. Circulation 2011, 124:704-711. 10.1161/CIRCULATIONAHA.110.985911, 21768543.
26. Kilpatrick ES, Rigby AS, Atkin SL. For debate. Glucose variability and diabetes complication risk: we need to know the answer. Diabet Med 2010, 27:868-871.
27. Lipska KJ, Venkitachalam L, Gosch K, Kovatchev B, Van den Berghe G, Meyfroidt G, Jones PG, Inzucchi SE, Spertus JA, DeVries JH, Kosiborod M. Glucose variability and mortality in patients hospitalized with acute myocardial infarction. Circ Cardiovasc Qual Outcomes 2012, 5:550-557. 10.1161/CIRCOUTCOMES.111.963298, 22693348.
28. Siegelaar SE, Kerr L, Jacober SJ, Devries JH. A decrease in glucose variability does not reduce cardiovascular event rates in type 2 diabetic patients after acute myocardial infarction: a reanalysis of the HEART2D study. Diabetes Care 2011, 34:855-857. 10.2337/dc10-1684, 3064040, 21447661.